首页> 美国卫生研究院文献>RNA Biology >An integrated framework for the identification of potential miRNA-disease association based on novel negative samples extraction strategy
【2h】

An integrated framework for the identification of potential miRNA-disease association based on novel negative samples extraction strategy

机译:基于新型阴性样品提取策略的潜在miRNA-疾病关联鉴定综合框架

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

MicroRNAs (miRNAs) play an important role in prevention, diagnosis and treatment of human complex diseases. Predicting potential miRNA-disease associations could provide important prior information for medical researchers. Therefore, reliable computational models are expected to be an effective supplement for inferring associations between miRNAs and diseases. In this study, we developed a novel calculative model named Negative Samples Extraction based MiRNA-Disease Association prediction (NSEMDA). NSEMDA filtered reliable negative samples by two positive-unlabeled learning models, namely, the Spy and Rocchio techniques and calculated similarity weights for ambiguous samples. The positive samples, reliable negative samples and ambiguous samples with similarity weights were used to construct a Support Vector Machine-Similarity Weight model to predict miRNA-disease associations. NSEMDA improved the credibility of negative samples and reduced the impact of noise samples by introducing ambiguous samples with similarity weights to train prediction model. As a result, NSEMDA achieved the AUC of 0.8899 in global leave-one-out cross validation (LOOCV) and AUC of 0.8353 under local LOOCV. In 100 times 5-fold cross validation, NSEMDA obtained an average AUC of 0.8878 and standard deviation of 0.0014. These AUCs are higher than many classical models. Besides, we also carried out three kinds of case studies to evaluate the performance of NSEMDA. Among the top 50 potential related miRNAs of esophageal neoplasms, lung neoplasms and carcinoma hepatocellular predicted by NSEMDA, 46, 50 and 45 miRNAs were verified to be associated with the investigated disease by experimental evidences, respectively. Therefore, NSEMDA would be a reliable calculative model for inferring miRNA-disease associations.
机译:微小RNA(miRNA)在人类复杂疾病的预防,诊断和治疗中起着重要作用。预测潜在的miRNA疾病关联可能为医学研究人员提供重要的先验信息。因此,可靠的计算模型有望成为推断miRNA与疾病之间联系的有效补充。在这项研究中,我们开发了一种新颖的计算模型,称为基于MiRNA-疾病关联预测(NSEMDA)的负样本提取。 NSEMDA通过两个未标记的正学习模型(即Spy和Rocchio技术)过滤了可靠的阴性样本,并为歧义样本计算了相似权重。使用具有相似权重的正样本,可靠负样本和模糊样本来构建支持向量机相似权重模型,以预测miRNA疾病关联。 NSEMDA通过将具有相似权重的模糊样本引入训练预测模型,提高了阴性样本的可信度,并减少了噪声样本的影响。结果,NSEMDA在全球一站式交叉验证(LOOCV)中获得了0.8899的AUC,在本地LOOCV下获得了0.8353的AUC。在100次5倍交叉验证中,NSEMDA获得的平均AUC为0.8878,标准偏差为0.0014。这些AUC高于许多经典模型。此外,我们还进行了三种案例研究,以评估NSEMDA的性能。 NSEMDA预测,在食管肿瘤,肺肿瘤和肝细胞癌的前50种潜在相关miRNA中,分别有46、50和45种miRNA与实验疾病相关。因此,NSEMDA将是推断miRNA-疾病关联的可靠计算模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号